Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions. Samplix and Innokas Medical started design and development related co-operation in the end of 2018, when Samplix chose Innokas Medical as their co-creation partner to develop the final commercial version of their innovation.

‍

“When our technology matured to the stage where we needed mass manufacturing of our instruments, we contacted a range of different companies to assess their OEM capabilities. Innokas Medical was selected based on having solid internal development capabilities including project management, mechanical, hardware and software engineering, as well as FDA approved production facilities capable of high-volume manufacturing at a competitive cost”, Marie Mikkelsen, CTO at Samplix. tells.

‍

The Danish company Samplix ApS, founded in 2012, provides the life sciences and medical research communities with cutting-edge microfluidics-based solutions. The Xdrop™ instrument is a droplet generator that can produce droplets with use of specific microfluidics dPCR and dMDA cartrides. It is operated from the touch screen and droplet generation is fully automated. Samplix also offers the complete range of reagents, cartridges and accessories for use with the Xdrop™ instrument.